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stoichiometric complex of either factor Xa, factor X, or pro-
thrombin and phospholipid-bound factor Va. In the presence
of factor Va LC. the dissociation constants of factor Xa- and
prothrombin-phospholipid complexes were increased, while
the maximal protein-binding capacities of the vesicles were
not affected by factor Va LC. The data suggest a competitive
interaction between factor Xa and factor Va LC binding as
well as between prothrombin and factor Va LC binding at the
phospholipid surface. From this, it is concluded that the
phospholipid-binding fragment of factor Va alone does not
serve as the binding site for interactions of factor Xa and
prothrombin with factor Va.
explain the effect of factor Va on the catalytic efficiency of
factor Xa. To that end. a role of factor Va in the formation
of the enzyme-substrate complex was proposed (Esmon &
Jackson, 1974; Rosing et al., 1980). However, quantitative
studies of the interaction of prothrombin with factor Va-
phospholipid complexes have not been reported.
In a recent report, Tracy & Mann (1983) described ex-
periments indicating that the interaction of factor Va with the
platelet surface is mediated primarily through factor Va LC,r
the 8000O-dalton subunit of factor Va. This observation is
consistent with our results using artificially prepared phos-
pholipid membranes (van de Waart et al., 1983). Tracy &
Mann (1983) suggested that the 80000-dalton subunit of
factor Va alone provides the binding site for the interaction
of factor Xa with platelet-bound factor Va. If artifically
prepared phospholipid membranes are a suitable model for the
biological membrane surface (platelets), then these results are
not in agreement with our observation that the calcium-me-
diated interaction between the subunits of factor Va is required
for factor Xa binding (Lindhout et al., 1982).
In this paper, we describe experiments indicating that the
binding of prothrombin to membranes containing acidic
phospholipids is facilitated by factor Va. We further dem-
onstrate that the phospholipid-binding subunit of factor Va
I Abbreviation: LC, light chain.
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ABsrRAcr: The effects of factor Va and the phospholipid-
binding fragment of factor Va [factor Va light chain (LC),
M, 80000] on the binding of prothrombin, factor X, and factor
Xa to phospholipid vesicles are reported. Equilibrium binding
experiments were performed that utilized large-volume vesicles,
which can be removed from the bulk solution by centrifugation.
Factor Va decreased the dissociation constant of the pro-
thrombin-phospholipid complex 50-fold, from 2.0 X l0-7 M
to 4.0 x lfe M. For the factor X-phospholipid complex the
decrease was 60-fold (1.8 x tO-z M to 3.0 x l0-e M) and for
factor Xa, 160-fold (1.6 x l0-7 M to 1.0 x l0-e M). The ratios
of moles of protein bound to moles of total added factor Va
at saturation ofphospholipid-bound factor Va indicate an 1:l
r
\-,onversion of prothrombin into thrombin by factor Xa is
most efficient in the presence of factor Va and membranes
containing acidic phospholipids. Rosing et al. (1980) dem-
onstrated that phospholipids lower the K. for prothrombin,
while factor Va increases the V^,, of thrombin formation.
Equilibrium binding experiments employing various tech-
niques have indicated that the interaction of prothrombin and
factor Xa with acidic phospholipid is mediated by calcium ions
(Nelsestuen & Lim, 1977;Mayer et al., 1983). However,
factor Va associates with membranes directly by interacting'
with the polar head groups of the acidic phospholipids (van
de Waart et al., 1983).
It is well appreciated that a phospholipid surface is required
for a proper assembly of the proteins involved in prothrombin
activation. The formation of the catalytic unit, a stoichiometric
(l:l) factor Xa-factor Va complex with a dissociation constant
of 3 x 104 M, is stimulated by acidic phospholipids, resulting
in a phospholipid-bound factor Xa-factor Va complex with
a dissociation constant of approximately 10-10 M (Nesheim
et al.,1979; Lindhout et al., 1982).
Localization of the prothrombinase complex on a phos-
pholipid surface per se, as facilitated by factor Va, does not
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(M, 80000) does not exhibit this effect but competes with
factor Va, factor'Xa, and prothrombin for the same phos-
pholipid-binding sites (i.e., acidic phospholipids).
Materials and Methods
Ovalbumin and 1,2-dioleoyl-sn-glycero-3-phosphocholine
(DOrc) were obtained from Sigma. All other chemicals were
of analytical grade. Factor Xa and thrombin activity was
determined with the chromogenic substrates N-benzoyl-r-
isoleucyl-l- glutamylpiperidylglycyl-r-arginine-p-nitroanilide
hydrochlorid e (52237 ) and H-o-phenylalanyl-l-pipecoyl-r,-
arginine-p-nitroanilide dihydrochloride (52238) (Kabi Diag-
nostics), respectively.
The following bovine clotting factors were prepared: pro-
thrombin (Owen et al.,1974), thrombin (Rosing et al., 1980),
factor V, factor Va, and factor Va subunits (Lindhout et al.,
1982), factor X (Fujikawa et al.,1972a), and factor Xa
(Fujikawa et al., 197 2b).
Functional molar concentrations of factor Va and factor Va
subunits, factor Xa, and prothrombin were estimated according
to van de Waart et al. (1983), van Dieijen et al. (1981), and
Rosing et al. (1980), respectively.
1,2-Dioleoyl-sn-glycero-3-phosphoserine (DOPS) was pre-
pared according to the method described by Comfurius &
Zwaal (1977).
Large-volume unilamellar vesicles were prepared by the
ether injection method according to Deamer & Bangham
(1976) as previously described (van de Waart et al., 1983).
Whenever a membrane composition is expressed as a per-
centage of acidic phospholipid, the remaining phospholipid is
DOPC.
Phospholipid concentrations were determined by the method
of Btittcher et al. (1961).
Binding of proteins to large-volume vesicles was quantitated
by measuring the molar concentrations of the proteins prior
to and after centrifugation for 30 min at 300009 and 20 oC.
Prior to centrifugation an equilibrium exists between free
protein and phospholipid-bound protein. So
Ka = S(F/B)
where K6 is the dissociation constant of the proteinlhos-
pholipid complex, Ss is the ooncentration of uncomplexed (free) -
binding sites, Fis the concentration offree protein, and B is
the concentration of bound protein. As sedimentation occurs,
both Sr and I increase and, so, K6 will not change. Therefore,
the equilibrium distribution is maintained after the separation
of the vesicles from the bulk solution. Protein binding data
were analyzed by double-reciprocal plots of the concentrations
of bound protein vs. free protein (van de Waart et al., 1983).
AU binding experiments were carried out in a buffer containing
50 mM tris(hydroxymethyl)aminomethane (Tris), 100 mM
NaCl, 0.5 mg of ovalbumin/ml, and 3 mM CaCl2, pH 7.5.
Results
Initial Experiments. Quantitative binding studies, em-
ployrng various techniques, on tle interaction of factor Xa with
artificially prepared membranes as well as with platelets in
the presence of factor Va have been reported (Nesheim et al.,
1979;Tracy et al., l98l; Lindhout et al., 1982).
As yet, no such studies have been described on the factor
Va-prothrombin interaction at a phospholipid surface. A
simple and direct binding technique, utilizing large-volume
vesicles that can be removed from the bulk solution by cen-
trifugation, is a valuable tool in the investigation of protein-
protein interactions at a phospholipid surface (van de Waart
et  a l . ,  1983).
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nrcune l: Binding of factor Xa to 5Vo DOPS (O) and 207o DOPS
(O) vesicles in the presence of varying concentrations of factor Va.
Binding measurements were made following a 10-min incubation. The
factor Xa concentration was kept constant at 2.0 X l0-7 M. The
phospholipid concentrations were either 2.0 x 10-4 (5% DOPS) or
5.0 X l0-' M (20Vo DOPS). Points are the means of three deter-
minations on separate mixtures.
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rrcure 2: Binding of prothrombin to 20Vo DOPS vesicles in the
presence ofvarying concentrations offactor Va. The prothrombin
concentration was kept constant at 2.0 x l0-? M. The phcpholipid
concentration was 1.0 x 10-4 M, Points are the means of tnree
determinations on separate mixtures.
Using this technique, we found that the amount of factor
Xa associated with vesicles containing 57o DOPS increased
dramatically between 0 and 0.7 pM factor Va added up to a
value approaching 1007o ofthe added factor Xa (Figure 1).
In the absence of factor Va, approximately lOVo of total added
factor Xa was associated with these vesicles. Vesicles con-
taining 207o DOPS instead of SVotnvea relatively high affinity
for factor Xa in the absence of factor Va and consequently
show a less pronounced facilitation of the binding by factor
Va.
Figure 2 shows that the amount of prothrombin associated
with vesicles that consist of 2OVo DOPS increased with in-
creasing factor Va concentration in the reaction mixture.
Contrary to the factor Va facilitated binding of factor Xa, the
gradual decrease in prothrombin associated with the vesicles
occurred in the presence of factor Va concentrations higher
than 0.3 pM. It is apparent that factor Va facilitated binding
of prothrombin to phospholipid can be observed when the
phospholipid-binding sites for prothrombin are not competively
removed by factor Va-phospholipid interaction.
The light-scattering technique cannot be used to establish
competition between two proteins for the same phospholipid-
binding sites, whereas the binding technique used here can.
This is seen from Figure 3. The phospholipid-binding prop-
erties of factor Xa were studied in the presence of various
amounts of factor X. The double-reciprocal plots of bound
vs. free factor Xa yield straight lines. The respective disso-
ciation constants were 2.1 x l0-? M. 4.2 x l0-7 M. and 1.0
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ncunr 4: Binding of prothrombin to vesicles in the presence of factor
Va. (Panel A) The amounts of bound and free prothrombin were
determined from reaction mixtures containing no (o), 3.0 x l0{ (A),
or 8.0 X 10-8 M (r) factor Va, varying amounts of prothrombin (0.1
x l0{ to 1.5 x 10-7 M), and 4.0 x 10-5 M phospholipid (207o DOPS).
(Panel B) Double reciprocal plots of the binding data from (A).
Table I: Prothrombin-, Factor X-, and Factor Xa-Factor Va
Binding Interactions at a Phospholipid Surface
fixed component
phospholipid
varied Vo
component DOPS
concn factor Va K4"oo
(M) concn (M) (M)
rrcunB 3: Binding of factor Xa (A and D), factor Va (B), and
prothrombin (C) to phospholipid (2OVo DOPS) in the presence of
varvins amounts offactor X and factor Va LC. Phospholipid con-
cenirat-ions were 2.5 x lo-5 (A), 1.0 x l0-5 (B), 1.0 x io{ (C1, ana
1 . 2 x 1 0 - 5 M ( D ) .
x 10-6 M for no factor X present and for 1.5 x l0-7 M and
3.0 x l0-7 M factor X present, respectively (Figure 3A). The
maximal binding capacity of the vesicles for factor Xa was
not affected by factor X, indicating that at infinitely large free
factor Xa concentration all factor X was displaced from the
phospholipid surface. These results are consistent with a
system of two ligands competing for one class of binding sites
with no mutual interactions.
In a completely analogous way, the apparent dissocation
constant of factor Va-phospholipid complexes increased with
the factor Va LC concentration (Figure 3B). The respective
dissociation constants were 2.0 x l0-8 M, 5.0 x l0-8 M, and
1.0 x l0-7 M for no factor Va LC present and for 1.0 x l0-7
M and 2.0 X 10-7 M factor Va LC present, respectively. The
competition between factor Va and factor Va LC for the
phospholipid binding sites confrrms earlier findings that factor
Va and factor Va LC have identical phospholipid-binding
properties (van de Waart et al., 1983).
Effect of Factor Va on Equilibrium Binding Data of Pro-
thrombin-, Factor X-, and Factor Xa-Phospholipid Inter-
qctions. Figure 4A shows that, in the absence of factor Va,
the ratio of phospholipid-bound prothrombin to free pro-
thrombin is constant. Apparently, the binding sites are in large
exc€ss over the prothrombin molecules. This is consistent with
a dissociation constant of 2 x l0-7 M and a maximal pro-
thrombin binding capacity of the vesicles of 2 x l0-7 M
prothrombin per 4 X l0-5 M phospholipid (van de Waart et
al., 1983). As indicated by the changes in B /F values, the
addition of amounts of factor Va, small as compared to the
amount of binding sites and comparable to the amount of
prothrombin added, lelds two distinct classes of prothrombin
binding sites.
Analysis of the binding data by double-reciprocal plots of
concentration of bound prothrombin vs. concentration of free
o Ratio of moles of protein bound to moles of total added factor
Va at saturation of phospholipid-bound factor Va.
prothrombin showed the presence of high-affinity and low-
affinity phospholipid-binding sites with dissociation constants
of 5 x ltre M and 1.5 x l0-7 M, respectively (Figure 4B).
It is apparent that the high-affinity binding sites comprise
factor Va-phospholipid complexes, because the number of
high-affinity sites increased with increasing amounts of added
factor Va and nearly l00Vo of added factor Va was found to
be associated with the vesicles. The apparent stoichiometries
between bound prothrombin and bound factor Va were 1.2 and
0.6 at 30 and 80 nM factor Va, respectively. The high number
of binding sites with a dissociation constant of - l0-7 is pro-
vided by noncomplexed phospholipid.
Decreasing the DOPS content of the vesicles increased the
apparent dissociation constant of prothrombin interaction with
phospholipid-bound factor Va, while the number of high-af-
finity sites appeared not to be dependent on the DOPS content
(Table I). This is consistent with the documented increase
of the dissociation constants of both proteins with decreasing
DOPS content in vesicles and with the observation that, under
the experimental conditions used in this study, the amount of
phospholipid-bound factor Va is not significantly dependent
on the DOPS content in vesicles.
For reasons of comparison, we investigated the effect of
factor Va on factor X and factor Xa binding to vesicles in a
similar set of experiments. As in the study with prothrombin,
factor Xa 20
l0
20
20
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20
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biphasic curves were obtained in all cases where factor Va was
included in the reaction mixtures (data not shown). The
respective binding parameters, obtained by linear extrapolation
of the data points in the double-reciprocal plot, that represent
the high-affinity interaction are shown in Table I, along with
the prothrombin binding data. The binding parameters for
the interaction between factor Xa and phospholipid-bound
factor Va compare with previous reported binding parameters
using sonicated vesicles (Nesheim et al., 1979; Lindhout et
a l . ,  1982).
As is also shown in Table I, the affinity of factor X for the
phospholipids is increased by two orders of magnitude by the
presence of factor Va. It is apparent that factor Xa binds more
tightly to phospholipid-bound factor Va than does the pro-
enzyme factor X; the binding constants are l.l X 104 M and
3.5 x l0-e M, respectively.
Association of Prothrombin and Factor Xa with Phos-
pholipid Vesicles in the Presence of Factor Va LC. The
association of prothrombin with vesicles containing 20% DOPS
was determined in the presence of varying amounts of factor
Va LC (Figure 3C). Contrary to the effect observed with
factor Va, the dissociation constant of prothrombin-phos-
pholipid complexes increased with increasing factor Va LC
concentrations, while the phospholipid to prothrombin ratio
at infinite free prothrombin concentration is independent of
the amount of factor Va LC present. The relationship between
the apparent dissociation constants of prothrombin-phos-
pholipid complexes and factor Va LC concentration indicates
that prothrombin and factor Va LC compete for phospho-
lipid-binding sites, i.e., acidic phospholipids. Furthermore, it
can be concluded that factor Va LC alone does not serve as
the binding site for interaction of prothrombin with factor Va.
Also, for the binding of factor Xa to phospholipid vesicles
in the presence of factor Va LC, a competition between factor
Xa and factor Va LC for the phospholipid-binding sites was
demonstrated (Figure 3D). It is apparent that the interaction
between factor Va and factor Xa at the phospholipid surface
is not mediated by factor Va LC.
Discussion
With the use of the simple and direct technique of equi-
librium binding on large-volume vesicles, we further studied
the role of factor Va in the assembly and function of the
prothrombinase complex. This paper describes as yet unre-
ported equilibrium binding experiments on factor Va-pro-
thrombin complex formation at a phospholipid surface. We
also investigated the structure-function relationship between
factor Va as well as its phospholipid-binding subunit (factor
Va LC) and the other components of the prothrombinase
complex, i.e., factor Xa and phospholipid as well as the sub-
strate of the prothrombinase complex prothrombin.
Previous studies of factor Xa-, factor Va-, and pro-
thrombin-phospholipid complexes indicate that the proteins
of the prothrombinase complex and the substrate of the com-
plex associate with membranes exclusively through interaction
of the proteins with the negatively charged polar head groups
of the phospholipids (Pusey et al., 1982; Mayer et al., 1983,
and references cited therein; van de Waart et al., 1983).
Clustering of acidic phospholipids in membranes of low PS
content (<20Vo) probably accompanies these protein-mem-
brane association processes (Mayer & Nelsestuen, l98l).
Taking these observations together, it is easy to conceive
that, depending on the respective protein-protein and pro-
tein-phospholipid affinities, coordinate and/or competitive
binding interactions might occur between proteins at the
phospholipid surface.
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The present studies provide several examples of competitive
as well as coordinate interactions that might be of importance
for prothrombin activation. It is apparent that factor X and
factor Xa compete for phospholipid-binding sites (Figure 3A).
This is consistent with the following observations: (1) the
dissociation constants of factor X- and factor Xa-phospholipid
complexes were found to be identical (van de Waart et al.,
1983), (2) one phospholipid-bound factor X and factor Xa
molecule covers about six phosphatidylserine molecules (Mayer
et al., 1983), and (3) factor Xa has a low affinity toward factor
X (Link & Castell ino, 1982).
Given the observations, that factor Xa binding to phos-
pholipid is essential to prothrombin activation and the com-
petitive binding interaction between factor X and factor Xa
for phospholipid-binding sites, the question arises whether the
presence of a large excess of the proenzyme factor X over
factor Xa might influence the conversion of prothrombin to
thrombin at a phospholipid surface (platelets) by factor Xa.
This question cannot be answered unless the interaction of
factor Xa with the protein components of the prothrombin-
prothrombinase complex are taken into account. To this end,
it is of interest to observe that factor Va facilitates the binding
of both factor X and factor Xa to the phospholipid surface
by decreasing the dissociation constant in the same order of
magnitude (60-fold and 160-fold, respectively; Table I). From
these results, the notion arises that factor X might be able to
remove factor Xa from factor Xa-factor Va complexes com-
petitively and thus reduce the amount of functional phos-
pholipid-bound enzyme. Preliminary data from kinetic studies
on prothrombin activation have given support to this possibility
(unpublished results).
Apart from its function in the assembly of the pro-
thrombinase complex, factor Va increases the catalytic effi-
ciency of the enzyme (Rosing et al., 1980). This suggests a
role for factor Va in the interaction between prothrombinase
and substrate (prothrombin). The equilibrium binding studies
presented here indicate that factor Va facilitates the binding
of prothrombin to the phospholipid surface. Under the con-
ditions of the experiments, of which the results are presented
in Table I. factor Va decreases the dissociation constant of
prothrombin-phospholipid (207o DOPS) complexes approxi-
mately 40-fold. We have to emphasize that we are dealing
with apparent dissociation constants, dependent on the DOPS
content of the vesicles. It appears from Figure 2 that, at high
factor Va concentrations, the amount of prothrombin bound
to the vesicle decreases with increasing factor Va concentration.
This strongly suggests that the additive effect of protein-
protein interaction as an important factor in facilitating the
binding of one of the components, i.e., prothrombin, to the
phospholipid surface is abolished by a competition with factor
Va for the same binding sites. In accordance with this notion,
there appears to be a 3-fold increase in the apparent disso-
ciation constant of prothrombin-phospholipid complexes in
the presence of factor Va when the DOPS content of the
vesicles is lowered ftom 2OVo to l0Vo (Table I). A comparison
of these results with the data obtained under identical con-
ditions from factor Xa binding studies in the presence of factor
Va reveals that (1) the apparent dissociation constant of factor
Xa-phospholipid complexes in the presence of factor Va is
approximately S-fold lower, (2) decreasing the DOPS content
ofthe vesicles has less effect on the dissociation constant, and
(3) factor Xa is not competitively removed from the phos-
pholipid by high factor Va concentrations (Figure l). These
findings can be qualitatively rationalized by assuming that the
affinity of prothrombin toward factor Va is much less than
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the affinity of factor Xa toward factor Va. The dissociation
constant of the latter complex in the absence of phospholipid
has been reported to be about 4 x 10-e M (Lindhout et al.,
1982).
Pusey et al. (1982) demonstrated by a kinetic analysis of
factor Va-phospholipid binding that, in comparison with factor
Xa, much higher concentrations of prothrombin and factor
X were required to slow factor Va-phospholipid dissociation.
They suggested that this presumably reflects a lower binding
affinity of prothrombin or factor X for factor Va.
A decrease of several orders of magnitude of the apparent
dissociation constant of prothrombinlhospholipid complexes
by factor Va might be relevant for prothrombin activation by
factor Xa. Kinetic studies carried out in our laboratory have
shown that factor Va greatly decreases the K. for prothrombin
when vesicles contain dioleoylphosphatidylglycerol or low
percentages of dioleoylphosphatidylserine (van Rijn et al.,
l  983) .
Another explanation for the additive effect of protein-
protein interaction as a dominant factor in the increase in
affinity of prothrombin to a phospholipid surface has to be
considered. It cannot be ruled out that acidic phospholipids
are clustered around a factor Va molecule. If so, factor Va
might modulate the phospholipid surface by providing a higher
negatively charged phospholipid content at its vicinity as
compared with the bulk surface. To this end, equilibrium
binding studies were performed that utilized the phospho-
lipid-binding subunit of factor Va (factor Va LC).
We demonstrated that the dissociation constants of factor
Xa-, prothrombin-, and factor Va-phospholipid complexes
increase with the concentration of factor Va LC. Because the
phospholipid-binding properties of factor Va LC are identical
with those of factor Va, we conclude from these observations
that modulation of the phospholipid surface by factor Va is
not enhancing the interaction of phospholipid with pro-
thrombinase proteins.
In addition, the results of this study also provide us with
information about the structurrfunction relationship between
factor Va subunits and the other protein components of the
prothrombinase complex, factor Xa, as well as prothrombin.
In contrast to the findings of Tracy & Mann (1983) utilizing
platelets, we could not establish that the 8000O-dalton com-
ponent of factor Va (factor Va LC) also serves as the binding
site for interaction of factor Xa with phospholipid-bound factor
Va. Our results confirm previously reported evidence that the
Ca2+-mediated interaction between the two subunits of factor
Va is required for binding of factor Va to factor Xa (Lindhout
et al., 1982).
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